Projects per year
- 50 - 100 out of 258 results
Search results
-
COSI: An international randomised clinical trial of therapeutic interventions with the potential to improve outcome in adults with acute myeloid leukaemia and high risk myelodysplasia undergoing allogeneic stem cell transplantation
Craddock, C. & Jackson, A.
Jazz Pharmaceuticals, ADIENNE s.r.l
1/09/19 → 31/12/26
Project: Industry
-
COVID19 BMT: A prospective non interventional study to evaluate the role of immune and inflammatory response in recipients of allogeneic haematopoietic stem cell transplantation (SCT) affected by severe COVID19 infection
Bishop, R., Craddock, C. & Jackson, A.
1/08/20 → 31/12/25
Project: Industry
-
CRISP: A phase Ib of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies (Study ITCC 053)
Fenwick, N., Kearns, P. & Seaford, E.
Cancer Research Uk, Erasmus Univesitair Medisch Centrum
1/04/18 → 31/10/24
Project: Research
-
CRUK/13/026: CompARE: Phase III randomised controlled trial Comparing Alternative Regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer
Gaunt, P., Billingham, L., Mehanna, H. & Bowden, S.
Cancer Research Uk, ASTRA ZENECA UK LIMITED, CITY HOSPITAL NHS TRUST
1/11/14 → 31/12/25
Project: Research
-
CRUK/17/011 FaR-RMS: A multiarm-multistage study for children and adults with localised and metastatic frontline and relapsed RhabdoMyoSarcoma.
Kearns, P., Gatz, S., Liu, W., Gaunt, P., Jackson, A. & Pirrie, S.
Cancer Research Uk, SIOP Europe
1/02/18 → 31/01/28
Project: Research
-
CRUK/17/013 E-smart : European proof of concept therapeutic stratification trial of molecular anomalies in replapsed or refractory tumours in children(E-smart)
Kearns, P., Fenwick, N. & Gough, R.
1/11/17 → 28/02/25
Project: Research
-
CRUK CRCTU Core Funding
Fisher, B., Billingham, L., Bach, S., Kearns, P., Pratt, G., Bowden, S., Rea, D., Middleton, G. & Gates, S.
1/10/23 → 30/09/28
Project: Research
-
-
Cryo-EM studies of a metazoan replisome captured ex vivo during elongation and termination
Biotechnology & Biological Sciences Research Council
1/03/24 → 28/02/27
Project: Research Councils
-
-
-
Defining genomic, pharmacological and microenvironmental contexts in which to target a protein hydroxylase
Stankovic, T., Coleman, M. & Tennant, D.
1/09/20 → 31/12/24
Project: Research
-
-
Development of a novel repurposed drug treatment for neurodegeneration and diabetes in Wolfram syndrome
Nagy, Z., Peet, A., Brock, K., Barrett, T. & Martin, U.
1/03/17 → 28/02/25
Project: Research Councils
-
-
Dissecting SUMO Activating Enzyme Pathways to Inform Therapy
12/01/23 → 30/11/25
Project: Research Councils
-
Drosophila Down Syndrome Cell Adhesion Module: A paradigm for revealing hidden splicing codes
Biotechnology & Biological Sciences Research Council
1/03/21 → 30/11/25
Project: Research Councils
-
Elucidating the influence of CCL21 on immunotherapies for ovarian cancer
25/03/22 → 24/09/24
Project: Research
-
EME -A Phase II Randomised Clinical Trial of Conditioning Cyclophosphamide and Chemoembiolisation with or without Vaccination with Dendritic Cells Pulsed with HepG2 Lysate in vivo in Patients with Hepatocellular Carcinoma : IMMUNOTACE Trial
Barton, D., Steven, N., Adams, D. & Gough, R.
1/01/13 → 31/12/25
Project: Other Government Departments
-
eRaDicate - Innovative ligands for nuclear receptors to eradicate cancer relapse
Hoogenkamp, M., Brown, G. & Stanulovic, V.
UKRI Horizon Europe Underwriting – EPSRC
1/01/24 → 31/12/27
Project: Research
-
Evaluation of the prognostic and predictive significance of fusion genes in epithelial ovarian cancer
1/09/22 → 31/12/24
Project: Industry
-
Exploring the tissue-specific disease mechanisms underlying tRNA- synthetase-associated peripheral neuropathies
Cazier, J.
The Research Foundation - Flanders (FWO)
1/02/23 → 31/12/25
Project: Research
-
FAecal microbiota transplantation in primaRy sclerosinG chOlangitis: The FARGO trial
Trivedi, P., Beggs, A. & Gates, S.
1/03/22 → 28/02/26
Project: Research
-
FaR-RMS - An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma
Bowden, S., Kearns, P., Gatz, S., Pirrie, S., Jackson, A., Liu, W. & Gaunt, P.
1/01/21 → 30/06/31
Project: EU
-
FEDORA: A phase II study to evaluate the safety, toxicity and tolerability of the combination of fedratinib and ropeginterferon alfa-2b, in patients with myelofibrosis
Fox, S., Craddock, C. & Jackson, A.
AOP Orphan Pharmaceuticals GmbH
31/12/21 → 30/06/26
Project: Research
-
FEDORA - A phase II study to evaluate the tolerability, safety and activity of fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis
Jackson, A., Fox, S. & Craddock, C.
3/12/21 → 30/06/26
Project: Industry
-
Fellowship in Computational Toxicology with the Food Standards Agency
Viant, M., Cazier, J., Zhou, J., Colbourne, J. & Weber, R.
2/08/21 → 1/08/25
Project: Other Government Departments
-
Fluid-Gels as Resorbable Protective Dressings for Ocular Surface Disease
Slade, A., Rauz, S. & Slade, A.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/03/19 → 30/09/24
Project: Other Government Departments
-
Functional genomics of aneuploidy in Oesophageal Adenocarcinoma
Middleton, G., Contino, G. & Beggs, A.
1/09/20 → 31/08/24
Project: Research
-
Genetic determinants of Oxaliplatin induced-peripheral neuropathy.
Ahmed, Z., Palles, C. & Tuxworth, R.
4/09/23 → 3/09/26
Project: Research
-
Global Study of Novel Agents in relapsed and refractory B-NHL with ADCT
Billingham, L., Kearns, P., Siddique, S. & Holt, G.
1/08/21 → 31/01/28
Project: Industry
-
Glo-BNHL: ADCT Collaboration: A Global Study of Novel Agents in Relapsed and Refractory B-Non Hodgkin Lymphoma
Bishop, R., Maycock, S., Kearns, P. & Billingham, L.
1/07/23 → 30/06/27
Project: Industry
-
Glo-BNHL: BMS Collaboration: A Global Study of Novel Agents in Relapsed and Refractory B-Non Hodgkin Lymphoma
Billingham, L., Bishop, R., Burke, A., Lawson, A. & Maycock, S.
BRISTOL MYERS SQUIBB PHARMACEUTICALS
1/05/24 → 30/04/29
Project: Industry
-
Glo-BNHL: Regeneron Collaboration - A Global Study Of Novel Agents In Relapsed And Refractory B-Non Hodgkin Lymphoma (B-NHL)
Kearns, P., Billingham, L., Maycock, S., Holt, G. & Siddique, S.
1/07/23 → 30/06/28
Project: Industry
-
Glo-BNHL Platform (full): [CR-UK] ACCELERATE platform study for relapsed and refractory B cell non-Hodgkin's lymphoma (B-NHL)
Billingham, L., Kearns, P., Seaford, E. & Maycock, S.
1/05/22 → 30/04/25
Project: Research
-